Topic Highlight
Copyright ©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 14, 2014; 20(14): 3858-3874
Published online Apr 14, 2014. doi: 10.3748/wjg.v20.i14.3858
Figure 1
Figure 1 Prevalence of epidermal growth factor receptor pathway deregulations and response to monoclonal antibodies targeting epidermal growth factor receptor in chemotherapy-refractory advanced colorectal cancer.